Research Summary
Quetiapine fumarate is a medication belonging to the class of atypical antipsychotics. It is commonly prescribed under the brand name Seroquel. Quetiapine is used to treat various psychiatric disorders, including schizophrenia, bipolar disorder, and major depressive disorder. The drug works by affecting the balance of neurotransmitters, particularly serotonin and dopamine, in the brain. It has antagonistic effects on certain receptors, which contribute to its therapeutic actions. Quetiapine is known for its efficacy in alleviating symptoms such as hallucinations, delusions, mood swings, and disturbances in thought patterns associated with psychiatric conditions. Additionally, it is sometimes used as an adjunct treatment for certain anxiety disorders. As with any medication, its use involves considerations of potential side effects, and patients are typically prescribed quetiapine under the supervision and guidance of healthcare professionals.
According to DIResearch's in-depth investigation and research, the global Quetiapine Fumarate market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Quetiapine Fumarate include AstraZeneca, Intas, TAPI, Accord, Hexal, Dr.Reddy's, Lupin, Sun Pharmaceutical, Hunan Dongting Pharm, SuZhou NO.4 Phamaceutical Factory, Fuan Pharmaceutical, Zhejiang Supor Pharmaceuticals, Zhejiang Huahai Pharmaceutical etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Quetiapine Fumarate. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Quetiapine Fumarate market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Quetiapine Fumarate market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Quetiapine Fumarate industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Quetiapine Fumarate Include:
AstraZeneca
Intas
TAPI
Accord
Hexal
Dr.Reddy's
Lupin
Sun Pharmaceutical
Hunan Dongting Pharm
SuZhou NO.4 Phamaceutical Factory
Fuan Pharmaceutical
Zhejiang Supor Pharmaceuticals
Zhejiang Huahai Pharmaceutical
Quetiapine Fumarate Product Segment Include:
Immediate Release Tablets
Extended Release Tablets
Quetiapine Fumarate Product Application Include:
Schizophrenia
Bipolar Disorder
Major Depressive Disorder (MDD)
Generalized Anxiety Disorder (GAD)
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Quetiapine Fumarate Industry PESTEL Analysis
Chapter 3: Global Quetiapine Fumarate Industry Porter's Five Forces Analysis
Chapter 4: Global Quetiapine Fumarate Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Quetiapine Fumarate Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Quetiapine Fumarate Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Quetiapine Fumarate Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Quetiapine Fumarate Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Quetiapine Fumarate Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Quetiapine Fumarate Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Quetiapine Fumarate Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Quetiapine Fumarate Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Quetiapine Fumarate Market Overview 1.1 Product Definition and Statistical Scope 1.2 Quetiapine Fumarate Product by Type 1.2.1 Global Quetiapine Fumarate Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 Immediate Release Tablets 1.2.3 Extended Release Tablets 1.3 Quetiapine Fumarate Product by Application 1.3.1 Global Quetiapine Fumarate Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Schizophrenia 1.3.3 Bipolar Disorder 1.3.4 Major Depressive Disorder (MDD) 1.3.5 Generalized Anxiety Disorder (GAD) 1.4 Global Quetiapine Fumarate Market Revenue and Sales Analysis 1.4.1 Global Quetiapine Fumarate Market Size Analysis (2019-2030) 1.4.2 Global Quetiapine Fumarate Market Sales Analysis (2019-2030) 1.4.3 Global Quetiapine Fumarate Market Sales Price Trend Analysis (2019-2030) 1.5 Quetiapine Fumarate Market Development Status and Trends 1.5.1 Quetiapine Fumarate Industry Development Status Analysis 1.5.2 Quetiapine Fumarate Industry Development Trends Analysis 2 Quetiapine Fumarate Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Quetiapine Fumarate Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Quetiapine Fumarate Market Analysis by Regions 4.1 Quetiapine Fumarate Overall Market: 2023 VS 2024 VS 2030 4.2 Global Quetiapine Fumarate Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Quetiapine Fumarate Revenue and Market Share by Region (2019-2024) 4.2.2 Global Quetiapine Fumarate Revenue Forecast by Region (2025-2030) 4.3 Global Quetiapine Fumarate Sales and Forecast Analysis (2019-2030) 4.3.1 Global Quetiapine Fumarate Sales and Market Share by Region (2019-2024) 4.3.2 Global Quetiapine Fumarate Sales Forecast by Region (2025-2030) 4.4 Global Quetiapine Fumarate Sales Price Trend Analysis (2019-2030) 5 Global Quetiapine Fumarate Market Size by Type and Application 5.1 Global Quetiapine Fumarate Market Size by Type 5.1.1 Global Quetiapine Fumarate Revenue and Forecast Analysis by Type (2019-2030) 5.1.2 Global Quetiapine Fumarate Sales and Forecast Analysis by Type (2019-2030) 5.2 Global Quetiapine Fumarate Market Size by Application 5.2.1 Global Quetiapine Fumarate Revenue and Forecast Analysis by Application (2019-2030) 5.2.2 Global Quetiapine Fumarate Sales and Forecast Analysis by Application (2019-2030) 6 North America 6.1 North America Quetiapine Fumarate Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Quetiapine Fumarate Market Size by Type 6.3.1 North America Quetiapine Fumarate Sales by Type (2019-2030) 6.3.2 North America Quetiapine Fumarate Revenue by Type (2019-2030) 6.4 North America Quetiapine Fumarate Market Size by Application 6.4.1 North America Quetiapine Fumarate Sales by Application (2019-2030) 6.4.2 North America Quetiapine Fumarate Revenue by Application (2019-2030) 6.5 North America Quetiapine Fumarate Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Quetiapine Fumarate Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Quetiapine Fumarate Market Size by Type 7.3.1 Europe Quetiapine Fumarate Sales by Type (2019-2030) 7.3.2 Europe Quetiapine Fumarate Revenue by Type (2019-2030) 7.4 Europe Quetiapine Fumarate Market Size by Application 7.4.1 Europe Quetiapine Fumarate Sales by Application (2019-2030) 7.4.2 ? Europe Quetiapine Fumarate Revenue by Application (2019-2030) 7.5 Europe Quetiapine Fumarate Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Quetiapine Fumarate Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Quetiapine Fumarate Market Size by Type 8.3.1 China Quetiapine Fumarate Sales by Type (2019-2030) 8.3.2 China Quetiapine Fumarate Revenue by Type (2019-2030) 8.4 China Quetiapine Fumarate Market Size by Application 8.4.1 China Quetiapine Fumarate Sales by Application (2019-2030) 8.4.2 China Quetiapine Fumarate Revenue by Application (2019-2030) 9 APAC (excl. China) 9.1 APAC (excl. China) Quetiapine Fumarate Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Quetiapine Fumarate Market Size by Type 9.3.1 APAC (excl. China) Quetiapine Fumarate Sales by Type (2019-2030) 9.3.2 APAC (excl. China) Quetiapine Fumarate Revenue by Type (2019-2030) 9.4 APAC (excl. China) Quetiapine Fumarate Market Size by Application 9.4.1 APAC (excl. China) Quetiapine Fumarate Sales by Application (2019-2030) 9.4.2 APAC (excl. China) Quetiapine Fumarate Revenue by Application (2019-2030) 9.5 APAC (excl. China) Quetiapine Fumarate Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Quetiapine Fumarate Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Quetiapine Fumarate Market Size by Type 10.3.1 Latin America Quetiapine Fumarate Sales by Type (2019-2030) 10.3.2 Latin America Quetiapine Fumarate Revenue by Type (2019-2030) 10.4 Latin America Quetiapine Fumarate Market Size by Application 10.4.1 Latin America Quetiapine Fumarate Sales by Application (2019-2030) 10.4.2 Latin America Quetiapine Fumarate Revenue by Application (2019-2030) 10.5 Latin America Quetiapine Fumarate Market Size by Country 10.5.1 Mexico 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Quetiapine Fumarate Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Quetiapine Fumarate Market Size by Type 11.3.1 Middle East & Africa Quetiapine Fumarate Sales by Type (2019-2030) 11.3.2 Middle East & Africa Quetiapine Fumarate Revenue by Type (2019-2030) 11.4 Middle East & Africa Quetiapine Fumarate Market Size by Application 11.4.1 Middle East & Africa Quetiapine Fumarate Sales by Application (2019-2030) 11.4.2 Middle East & Africa Quetiapine Fumarate Revenue by Application (2019-2030) 11.5 Middle East & Africa Quetiapine Fumarate Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Competition by Manufacturers 12.1 Global Quetiapine Fumarate Market Sales, Revenue and Price by Key Manufacturers (2020-2024) 12.1.1 Global Quetiapine Fumarate Market Sales by Key Manufacturers (2020-2024) 12.1.2 Global Quetiapine Fumarate Market Revenue by Key Manufacturers (2020-2024) 12.1.3 Global Quetiapine Fumarate Average Sales Price by Manufacturers (2020-2024) 12.2 Quetiapine Fumarate Competitive Landscape Analysis and Market Dynamic 12.2.1 Quetiapine Fumarate Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 AstraZeneca 13.1.1 AstraZeneca Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 AstraZeneca Quetiapine Fumarate Product Portfolio 13.1.3 AstraZeneca Quetiapine Fumarate Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.2 Intas 13.2.1 Intas Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 Intas Quetiapine Fumarate Product Portfolio 13.2.3 Intas Quetiapine Fumarate Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.3 TAPI 13.3.1 TAPI Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 TAPI Quetiapine Fumarate Product Portfolio 13.3.3 TAPI Quetiapine Fumarate Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.4 Accord 13.4.1 Accord Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 Accord Quetiapine Fumarate Product Portfolio 13.4.3 Accord Quetiapine Fumarate Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.5 Hexal 13.5.1 Hexal Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 Hexal Quetiapine Fumarate Product Portfolio 13.5.3 Hexal Quetiapine Fumarate Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.6 Dr.Reddy's 13.6.1 Dr.Reddy's Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 Dr.Reddy's Quetiapine Fumarate Product Portfolio 13.6.3 Dr.Reddy's Quetiapine Fumarate Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.7 Lupin 13.7.1 Lupin Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 Lupin Quetiapine Fumarate Product Portfolio 13.7.3 Lupin Quetiapine Fumarate Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.8 Sun Pharmaceutical 13.8.1 Sun Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.8.2 Sun Pharmaceutical Quetiapine Fumarate Product Portfolio 13.8.3 Sun Pharmaceutical Quetiapine Fumarate Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.9 Hunan Dongting Pharm 13.9.1 Hunan Dongting Pharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.9.2 Hunan Dongting Pharm Quetiapine Fumarate Product Portfolio 13.9.3 Hunan Dongting Pharm Quetiapine Fumarate Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.10 SuZhou NO.4 Phamaceutical Factory 13.10.1 SuZhou NO.4 Phamaceutical Factory Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.10.2 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Product Portfolio 13.10.3 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.11 Fuan Pharmaceutical 13.11.1 Fuan Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.11.2 Fuan Pharmaceutical Quetiapine Fumarate Product Portfolio 13.11.3 Fuan Pharmaceutical Quetiapine Fumarate Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.12 Zhejiang Supor Pharmaceuticals 13.12.1 Zhejiang Supor Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.12.2 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Product Portfolio 13.12.3 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.13 Zhejiang Huahai Pharmaceutical 13.13.1 Zhejiang Huahai Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.13.2 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Product Portfolio 13.13.3 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Quetiapine Fumarate Industry Chain Analysis 14.2 Quetiapine Fumarate Industry Upstream Supply Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Quetiapine Fumarate Typical Downstream Customers 14.4 Quetiapine Fumarate Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support